DRVVT Positive Meaning
A positive dilute Russell viper venom time (DRVVT) indicates the presence of a lupus anticoagulant (LA), which is a phospholipid-dependent inhibitor associated with antiphospholipid syndrome (APS) and increased thrombotic risk.
What DRVVT Detects
The DRVVT is one of the two recommended screening tests for detecting lupus anticoagulants 1. Despite its name, lupus anticoagulant is actually a prothrombotic antibody that paradoxically prolongs clotting times in laboratory testing while increasing clot formation risk in vivo.
Interpretation Algorithm
A positive DRVVT result requires three sequential steps to confirm true LA positivity 1:
- Prolonged screening test - Initial DRVVT screen shows prolonged clotting time
- Negative mixing study - Adding normal plasma fails to correct the prolongation (distinguishes LA from clotting factor deficiencies)
- Positive confirmatory test - Adding excess phospholipids corrects the prolongation (confirms phospholipid-dependent inhibitor)
Only when all three criteria are met should LA be interpreted as present 1.
Clinical Significance
Risk stratification depends on the complete antiphospholipid antibody profile 1:
- Triple-positive patients (LA + anticardiolipin + anti-β2GPI antibodies) have the highest thrombotic risk and require aggressive management
- Isolated LA positivity carries lower but still significant thrombotic risk compared to triple positivity 1
- LA positivity is mandatory for diagnosing high-risk APS patients 1
Critical Pitfalls to Avoid
Anticoagulation Interference
Testing during anticoagulation is strongly discouraged as it causes both false-positive and false-negative results 1:
- Warfarin/VKA therapy: Can cause false-negative results due to factor deficiency; LA should be reported as absent with comment about potential false-negative 1
- Direct oral anticoagulants (DOACs): Cause variable effects on DRVVT, with rivaroxaban having the greatest interference 2. DOAC removal agents may be used, but incomplete removal can still cause false-positives 1
- Heparin: Must be excluded before interpretation 3
Inflammation Effects
High C-reactive protein levels can prolong DRVVT clotting times, potentially causing false-positive results 4. Exercise caution when interpreting LA testing in patients with active inflammation.
Confirmation Requirements
A single positive DRVVT is insufficient for APS diagnosis. The test must be repeated at least 12 weeks later to confirm persistence 1. Transient LA positivity (from infection, medications, or other causes) does not confer the same thrombotic risk as persistent positivity.
Why DRVVT Should Not Be Used Alone
Current guidelines mandate using both DRVVT and LA-sensitive APTT in parallel 1. Omitting either test increases the risk of missing LA in up to 55% of triple-positive patients and 31% of APS patients 1. The two tests detect different populations of antiphospholipid antibodies, making combined testing essential for adequate sensitivity.
When DRVVT Positivity Matters Most
DRVVT positivity has the strongest clinical correlation when:
- Both ISTH and manufacturer criteria are met 5
- Other APS tests are also positive (anticardiolipin, anti-β2GPI antibodies) 5
- Clinical thrombotic or obstetric manifestations are present 6
Patients with DRVVT results meeting only one set of positivity criteria rarely receive an APS diagnosis 5.